PTC Therapeutics Inc.
42.44
0.63 (1.51%)
At close: Jan 15, 2025, 11:07 AM

PTC Therapeutics Inc. Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024Dec 31, 2023Jun 30, 2023Mar 31, 2023Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019
Manufacturing Revenue 800.00K 1.36M 3.34M 2.36M 1.99M 103.11M 91.28M 107.26M 82.71M 75.24M 68.20M 81.41M 71.37M 85.48M
Manufacturing Revenue Growth -41.18% -59.23% +41.18% +18.86% -98.07% +12.96% -14.90% +29.68% +9.93% +10.33% -16.23% +14.06% -16.50% n/a
Product Revenue 135.42M n/a n/a n/a n/a n/a n/a 4.09M 696.00K n/a n/a n/a n/a n/a
Product Revenue Growth n/a n/a n/a n/a n/a n/a n/a +487.64% n/a n/a n/a n/a n/a n/a
Royalty Revenue 61.37M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Royalty Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Non-Us Revenue 406.16M 288.60M 236.00M 190.30M 171.04M 145.24M 81.50M
Non-Us Revenue Growth +40.73% +22.29% +24.01% +11.26% +17.77% +78.21% n/a
United States Revenue 531.66M 218.30M 187.30M n/a n/a n/a n/a
United States Revenue Growth +143.55% +16.55% n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 73.46M 69.50M 73.27M 76.29M 80.89M 88.45M 86.91M 92.72M 80.12M 79.89M 73.27M 86.55M 69.25M 68.88M 61.09M 75.46M 57.84M 53.66M 58.21M 63.50M 49.28M 49.22M 40.54M 48.67M 38.37M 33.55M 32.97M 35.48M 31.42M 28.87M 25.50M 24.17M 23.65M 23.37M 25.94M 25.89M 21.37M 17.21M 17.61M
Selling, General, and Administrative Revenue Growth +5.69% -5.15% -3.96% -5.68% -8.55% +1.77% -6.26% +15.73% +0.28% +9.04% -15.34% +24.98% +0.54% +12.74% -19.03% +30.46% +7.79% -7.82% -8.33% +28.84% +0.14% +21.39% -16.69% +26.84% +14.38% +1.75% -7.08% +12.92% +8.86% +13.20% +5.49% +2.19% +1.23% -9.92% +0.20% +21.15% +24.16% -2.30% n/a
Research and Development Revenue 161.41M 132.17M 116.13M 121.35M 164.21M 185.87M 195.12M 188.69M 165.46M 157.26M 140.08M 149.84M 130.84M 125.48M 134.51M 118.01M 93.00M 176.53M 90.11M 81.83M 63.08M 59.98M 52.57M 53.65M 54.37M 32.61M 31.36M 29.23M 30.02M 30.84M 27.36M 26.01M 31.40M 28.83M 31.40M 35.05M 30.64M 28.19M 27.94M
Research and Development Revenue Growth +22.13% +13.81% -4.30% -26.10% -11.65% -4.74% +3.41% +14.04% +5.21% +12.27% -6.52% +14.52% +4.27% -6.71% +13.98% +26.90% -47.32% +95.91% +10.11% +29.73% +5.16% +14.10% -2.02% -1.33% +66.74% +3.97% +7.28% -2.63% -2.63% +12.69% +5.20% -17.15% +8.91% -8.19% -10.41% +14.39% +8.69% +0.90% n/a

Create Price Alert on PTCT

Your price alert will notify you when the stock price is above 42.44.

Add to Watchlist